NASDAQ:BCEL
Atreca Inc. Stock News
$0.0902
-0.0060 (-6.23%)
At Close: May 03, 2024
Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101
01:00pm, Tuesday, 03'rd Dec 2019
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on the development of novel cancer therapeutics generated through a unique discovery platform based on interrogation of the active
Op Ed: Want to Learn About Bitcoin? Try Contributing a Transcript
06:37pm, Tuesday, 26'th Nov 2019
Contributing to or reading the Bitcoin archive of transcripts maintained by Bryan Bishop (kanzure) can be highly valuable and educational.
Atreca to Present at Two Upcoming Investor Conferences
01:00pm, Thursday, 14'th Nov 2019
REDWOOD CITY, Calif., Nov. 14, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
Atreca Reports Third Quarter 2019 Financial Results and Recent Corporate Developments
09:05pm, Tuesday, 12'th Nov 2019
REDWOOD CITY, Calif., Nov. 12, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
01:00pm, Tuesday, 05'th Nov 2019
REDWOOD CITY, Calif., Nov. 05, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
Common IRS Where's My Refund Questions
07:15am, Tuesday, 29'th Oct 2019
Our FAQ of the most common IRS Where's My Refund Questions, Errors, Comments, Concerns, and more.
The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
12:14pm, Friday, 11'th Oct 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 10.) The Medicines Company (NASDAQ: MDCO ) Ra
Do Institutions Own Shares In Atreca, Inc. (NASDAQ:BCEL)?
01:19pm, Thursday, 19'th Sep 2019
Every investor in Atreca, Inc. (NASDAQ:BCEL) should be aware of the most powerful shareholder groups. Institutions...
Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors
08:05pm, Monday, 26'th Aug 2019
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today announced the appointment of L
Another PTAB Casualty: Emmy Awarded Wireless Microphone Technology Could Be Invalidated
09:15pm, Tuesday, 13'th Aug 2019
On October 25, the AIPLA Annual Meeting will host a Patent Trial and Appeal Board (PTAB) Inter Partes Review (IPR) trial to determine the fate of a pair of patents issued by the U.S. Patent and Tradem
Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments
08:05pm, Tuesday, 13'th Aug 2019
REDWOOD CITY, Calif., Aug. 13, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
What It’s Like to Review Bitcoin's Code - CoinDesk
12:00pm, Friday, 19'th Jul 2019
CoinDesk dives deep into the complex process of reviewing code for the Bitcoin Core software.
Stifel: Atreca Offers Attractive Oncology Drug Development Play
06:22pm, Monday, 15'th Jul 2019
Atreca has a highly differentiated approach to antibody drug discovery that moves completely away from the biologically or genetically derived hypotheses that are traditionally used to inform target s
Atreca, Inc. (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, today announced the appointment of Lisa L. Dec
Atreca Opens For Trade
03:16pm, Thursday, 20'th Jun 2019
Atreca, Inc. (NASDAQ: BCEL ) shares opened for trade Thursday morning at $19.90. The IPO of 7.35 million shares was priced at $17. Atreca is a biopharma company that uses its platform to discover and
